DNA Ginkgo Bioworks Holdings, Inc.

NYSE
$11.65

Ginkgo Bioworks Holdings, Inc. (DNA) SEC Filings

Everything DNA has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

63 filings
Date Form Filing
8-K Earnings Release View filing
8-K Earnings Date Announcement · Reg Fd View filing
4 View filing
4 View filing
4 View filing
4 View filing
144 View filing
144 View filing
144 View filing
144 View filing
144 View filing
144 View filing
4 View filing
144 View filing
144 View filing
4 View filing
144 View filing
4 View filing
144 View filing
10-Q View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
10-Q View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
10-K View filing
4 View filing
4 View filing
10-Q View filing
4 View filing
4 View filing
4 View filing
4 View filing
10-Q View filing
10-Q View filing
10-K View filing
10-Q View filing
10-Q View filing
10-Q View filing
10-K View filing
10-Q View filing
10-Q View filing
10-Q View filing
10-K View filing
10-Q View filing
10-K/A View filing
10-Q View filing
10-Q View filing
10-K View filing
10-Q View filing

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.